EZH2 and neoplasm: They indicated that MSC-derived exosomal miR-133b was capable of blocking glioma cell proliferation, invasion, and migration as well as tumor growth via the suppression of EZH2 through the blockade of the Wnt/β-catenin signaling pathway in in vitro as well as in vivo experiments (Figure 2) [100].